IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 205 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is 0.23 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,537 | +31.6% | 338 | +103.6% | 0.00% | – |
Q2 2023 | $1,168 | +15.2% | 166 | 0.0% | 0.00% | – |
Q1 2023 | $1,014 | +231.4% | 166 | +245.8% | 0.00% | – |
Q4 2022 | $306 | – | 48 | -50.0% | 0.00% | – |
Q3 2022 | $0 | -100.0% | 96 | -52.9% | 0.00% | – |
Q2 2022 | $1,000 | -75.0% | 204 | -19.7% | 0.00% | – |
Q1 2022 | $4,000 | -90.5% | 254 | -88.7% | 0.00% | – |
Q4 2021 | $42,000 | -63.8% | 2,257 | -51.8% | 0.00% | – |
Q3 2021 | $116,000 | +544.4% | 4,681 | +579.4% | 0.00% | – |
Q2 2021 | $18,000 | +50.0% | 689 | +80.4% | 0.00% | – |
Q1 2021 | $12,000 | -25.0% | 382 | +13.0% | 0.00% | – |
Q4 2020 | $16,000 | +60.0% | 338 | +4.6% | 0.00% | – |
Q3 2020 | $10,000 | +11.1% | 323 | -9.8% | 0.00% | – |
Q2 2020 | $9,000 | +200.0% | 358 | +219.6% | 0.00% | – |
Q1 2020 | $3,000 | 0.0% | 112 | +12.0% | 0.00% | – |
Q4 2019 | $3,000 | +50.0% | 100 | 0.0% | 0.00% | – |
Q3 2019 | $2,000 | 0.0% | 100 | 0.0% | 0.00% | – |
Q2 2019 | $2,000 | +100.0% | 100 | 0.0% | 0.00% | – |
Q1 2019 | $1,000 | 0.0% | 100 | 0.0% | 0.00% | – |
Q4 2018 | $1,000 | -92.3% | 100 | -90.9% | 0.00% | – |
Q3 2018 | $13,000 | +8.3% | 1,100 | +10.0% | 0.00% | – |
Q2 2018 | $12,000 | -25.0% | 1,000 | 0.0% | 0.00% | – |
Q1 2018 | $16,000 | +100.0% | 1,000 | 0.0% | 0.00% | – |
Q4 2017 | $8,000 | 0.0% | 1,000 | 0.0% | 0.00% | – |
Q3 2017 | $8,000 | 0.0% | 1,000 | -3.6% | 0.00% | – |
Q2 2017 | $8,000 | – | 1,037 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Perceptive Advisors | 12,201,261 | $203,150,000 | 4.07% |
Paradigm Biocapital Advisors LP | 907,428 | $15,109,000 | 4.00% |
Avoro Capital Advisors LLC | 9,125,000 | $151,931,000 | 2.77% |
Logos Global Management LP | 1,000,000 | $16,650,000 | 2.16% |
Avidity Partners Management LP | 6,043,219 | $100,620,000 | 2.10% |
Orbimed Advisors | 6,633,006 | $110,440,000 | 1.79% |
Parametrica Management Ltd | 134,679 | $2,240,000 | 1.66% |
Boxer Capital, LLC | 1,935,133 | $32,220,000 | 1.66% |
Fairmount Funds Management LLC | 389,588 | $6,487,000 | 1.53% |
Long Focus Capital Management, LLC | 705,000 | $11,738,000 | 1.51% |